Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Return on Equity (2016 - 2025)

Nephros (NEPH) has 15 years of Return on Equity data on record, last reported at 0.16% in Q3 2025.

  • For Q3 2025, Return on Equity rose 27.0% year-over-year to 0.16%; the TTM value through Sep 2025 reached 0.16%, up 27.0%, while the annual FY2024 figure was 0.01%, 19.0% up from the prior year.
  • Return on Equity reached 0.16% in Q3 2025 per NEPH's latest filing, up from 0.15% in the prior quarter.
  • Across five years, Return on Equity topped out at 0.16% in Q3 2025 and bottomed at 0.31% in Q2 2023.
  • Average Return on Equity over 5 years is 0.16%, with a median of 0.18% recorded in 2023.
  • Peak YoY movement for Return on Equity: decreased -14bps in 2023, then increased 30bps in 2025.
  • A 5-year view of Return on Equity shows it stood at 0.24% in 2021, then fell by -27bps to 0.31% in 2022, then skyrocketed by 41bps to 0.18% in 2023, then soared by 105bps to 0.01% in 2024, then surged by 1639bps to 0.16% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Equity were 0.16% in Q3 2025, 0.15% in Q2 2025, and 0.09% in Q1 2025.